Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoAnd, last month, Pfizer unveiled positive results from a lung cancer study. The company tested its ...
Blue Cross Blue Shield of Michigan dropping coverage of weight loss drugs
CBS News· 21 hours agoMichigan's largest insurance company said it will begin eliminating coverage of various weight loss...
Virtua Health offers innovative lung cancer-fighting drug
NJBIZ· 4 days agoMarlton-headquartered Virtua Health is the first South Jersey provider to offer a groundbreaking ...
University of North Florida researchers discover cancer-fighting compound, receive patent
FOX30 / CBS47 Jacksonville· 17 hours agoResearchers discovered a cancer-fighting compound and received a patent for it, using peptoids to...
NHS genomics testing will be vital in supporting personalised cancer trials
Clinical Trials Arena via Yahoo Finance· 9 hours agoPeter Johnson, national clinical director for cancer of NHS England said that the genomic medicine...
Study reveals unexpected mechanism of drug resistance in kidney cancer
Medical Xpress· 2 days agoFor nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Published in the Proceedings of the National Academy of ...
Xylyx Bio Awarded $2.26M NIH SBIR Grant from Natio | Newswise
Newswise· 13 hours agoAward supports development of a pre-clinical cell-based assay platform to help scientists discover and test drug candidates for metastatic breast cancer
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 6 hours agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Why many lung cancer patients who have never smoked have worse outcomes
Science Daily· 1 day agoThe study, published in Nature Communications, shows that lung cancer cells with two particular genetic mutations are more likely to double their genome, which helps them ...
Lantern Pharma secures Japan patent for cancer drug By Investing.com
Investing.com· 2 days agoLantern Pharma Inc. (NASDAQ:LTRN), a company leveraging artificial intelligence (AI) in cancer...